Immunocore Holdings Ltd (IMCR) — Free Cash Flow Generation Index

Latest as of June 2025: 0.98x

Immunocore Holdings Ltd (IMCR) has a Free Cash Flow Generation Index of 0.98x as of June 2025. Free cash flow of $25.55 Million represents 1% of operating cash flow ($25.96 Million). See working capital position of Immunocore Holdings Ltd to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.98x
Free Cash Flow / Operating CF

Free Cash Flow

$25.55 Million
USD

Operating Cash Flow

$25.96 Million
USD

Capital Expenditures

$414.00K
USD

Immunocore Holdings Ltd Free Cash Flow Generation Index (2023–2024)

Historical FCF Generation Index trend for Immunocore Holdings Ltd across 2 annual periods. Explore Immunocore Holdings Ltd (IMCR) cash flow to debt to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Immunocore Holdings Ltd (2023–2024)

Year-by-year Free Cash Flow Generation Index for Immunocore Holdings Ltd. For the full company profile including market capitalisation, see IMCR stock market capitalisation.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2024 0.80x $20.89 Million $26.06 Million $5.17 Million ▲ +194.8%
2023 -0.85x $-2.48 Million $2.94 Million $5.42 Million
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).